Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DANAPAROID vs DAPAGLIFLOZIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DANAPAROID vs DAPAGLIFLOZIN: Safety Overview

Metric DANAPAROID DAPAGLIFLOZIN
Total FAERS Reports 170 21,367
Deaths Reported 67 3,633
Death Rate 39.4% 17.0%
Hospitalizations 75 8,467
Average Patient Age 63.4 yrs 64.9 yrs
% Female Patients 63.1% 44.5%
FDA Approval Date Dec 24, 1996 Jan 8, 2014
Manufacturer N/A AstraZeneca Pharmaceuticals LP
Route N/A ORAL
Marketing Status Discontinued Prescription